Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of PerClot® Polysaccharide Hemostatic System (CLOT)
Sponsor: Artivion Inc.
Listed as NCT02359994, this NA trial focuses on Blood Loss, Surgical and remains completed. Sponsored by Artivion Inc., it has been updated 15 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
-
Feb 2021 — Apr 2022 [monthly]
Completed NA
-
Jan 2021 — Feb 2021 [monthly]
Completed NA
▶ Show 10 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Dec 2019 — Feb 2020 [monthly]
Completed NA
-
Apr 2019 — Dec 2019 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2019 — Apr 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2018 — Feb 2019 [monthly]
Recruiting NA
-
Sep 2018 — Oct 2018 [monthly]
Recruiting NA
-
Aug 2018 — Sep 2018 [monthly]
Recruiting NA
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Artivion Inc.
For direct contact, visit the study record on ClinicalTrials.gov .